|Bid||0.00 x 1300|
|Ask||0.00 x 800|
|Day's range||19.00 - 19.45|
|52-week range||18.22 - 29.53|
|Beta (5Y monthly)||0.60|
|PE ratio (TTM)||25.21|
|Forward dividend & yield||1.20 (6.18%)|
|Ex-dividend date||17 Nov 2022|
|1y target est||N/A|
The healthcare industry can make for a safe place to invest regardless of the macroeconomic conditions. A couple of healthcare stocks that are diversified and that could be good buys heading into the new year are AstraZeneca (NASDAQ: AZN) and PetMed Express (NASDAQ: PETS). AstraZeneca's business performed well in 2022, but its stock isn't doing as well as perhaps it should be.
PetMed (PETS) delivered earnings and revenue surprises of -51.85% and 0.61%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Amazon (AMZN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.